Results 231 to 240 of about 241,339 (286)

Anatomical distribution of bone metastases in stage IV breast cancer: According to histological subtype. [PDF]

World J Clin Oncol
Zari DS, Novak R, Haviv O, Ron I, Kaplan B, Awad B, Norman D, Nikomarov D.   +7 more
europepmc   +1 more source

Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy

BMEMat, EarlyView.
This review systematically summarizes cutting‐edge advances in glycolysis‐rewiring nanomedicines, emphasizing their mechanisms in reversing immunosuppression and reinvigorating antitumor immune responses. Challenges in clinical translation and future directions for designing multifunctional metabolic‐immune modulators are also critically discussed ...
Zilin Ma, Songyan Li, Jie Yan, Xuechun Wang, Wen Zhao, Yunxuan Song, Dongdong Liu, Jianwei Jiao, Xiuying Duan, Guiqiang Zhang   +9 more
wiley   +1 more source

Stereotactic body radiotherapy for spine and non-spine bone metastases in prostate carcinoma - a multicenter cohort analysis. [PDF]

J Bone Oncol
Nägler F, Seiler I, Schäfer S, Meents J, Lohaus F, Grün A, Wittenstein O, Klischies K, Remmele J, Rühle A, Eckl M, Blanck O, Boda-Heggemann J, Giordano FA, Moustakis C, Nicolay NH, Kästner L.   +16 more
europepmc   +1 more source

Marine silicon for biomedical sustainability

BMEMat, EarlyView.
Schematic illustrating marine silicon for biomedical engineering. Abstract Despite momentous divergence from oceanic origin, human beings and marine organisms exhibit elemental homology through silicon utilization. Notably, silicon serves as a critical constituent in multiple biomedical processes.
Yahui Han, Zhibo Yang, Wei Xia, Chengtie Wu   +3 more
wiley   +1 more source

Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study. [PDF]

J Bone Oncol
Taurisano P, Cornacchia E, De Caro MF, Fusco V, Ibrahim T, Ragno A, Salonne F, Paparella G, Betti M, Penpa S, Rossi M, Hakim R, Pierini M, Porta C, D'Oronzo S.   +14 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Risk factors for skeletal-related events in patients with stage IV lung adenocarcinoma and bone metastases receiving denosumab: a retrospective cohort analysis. [PDF]

Support Care Cancer
Zhang H, Wen D, Liao Z, Tan X, Wang H, Xiang J, Yan B.   +6 more
europepmc   +1 more source

A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy

BMEMat, EarlyView.
ZIF‐8‐based nanoparticles co‐delivering CB‐839 (glutaminase inhibitor) and 1‐MT (IDO1 inhibitor), dual‐targeting glutamine/tryptophan metabolism to induce immunogenic cell death, activate STING, block kynurenine production, reverse immunosuppression, and enhance cancer immunotherapy to suppress primary/distant tumors.
Wenli Ning, Yunhan Sun, Mingyang Li, Shilu Liu, Fangjie Yi, Hongfei Wang, Ruibing Bai, Dongdong Liu, Fen Zhao, Guiqiang Zhang, Xiao Fu   +10 more
wiley   +1 more source

Exploring Bone Oncology in a Medically Underserved Area: A Retrospective Cohort of Bone Metastases and Malignant Bone Neoplasia in the Rio Grande Valley. [PDF]

South Med J
Martin BC, Lopez-Alvarenga J, Sander MD.
europepmc   +1 more source